Owners, management and financials
CVR: 34483884
Previous names: ALTRAPHARMA ApS
DKK -88,915
Gross profit
Net result: DKK -84,944
ALTRA 14 ApS (66,66-89,99%), Juniwik Business Management AB (25-33,32%)
CVR · view owners
Marianne Thrane
CVR · view management
Active
Founded 18 April 2012
CVR · view overview
1 employee
CVR · 2025
Owner registered: ALTRA 14 ApS
CVR · 26/11/2025
View the full event history
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.
Selskabets formål er konsulent og rådgivningsvirksomhed. Eje værdipapirer samt anden formueanbringelse og driftsaktivitet. Eje og forvalte fast og løs ejendom samt al virksomhed, som efter ledelsens skøn har forbindelse hermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/07/2024 – 30/06/2025 | -89 t. | -85 t. | 145 t. | 104 t. | 1 | |
| 202401/07/2023 – 30/06/2024 | -43 t. | 87 t. | 240 t. | 89 t. | 0 | |
| 202301/07/2022 – 30/06/2023 | -67 t. | -67 t. | 182 t. | 2 t. | 0 | |
| 202201/07/2021 – 30/06/2022 | -172 t. | -484 t. | 249 t. | 69 t. | 1 | |
| 202101/07/2020 – 30/06/2021 | -76 t. | -146 t. | 808 t. | 554 t. | 0 | |
| 202001/07/2019 – 30/06/2020 | 527 t. | 407 t. | 961 t. | 699 t. | 0 | |
| 201901/07/2018 – 30/06/2019 | 158 t. | 110 t. | 452 t. | 292 t. | 0 | |
| 201701/01/2017 – 31/12/2017 | 473 t. | 270 t. | 1.8 mio. | 517 t. | 0 | |
| 201601/01/2016 – 31/12/2016 | 1.2 mio. | 67 t. | 1.5 mio. | 247 t. | 0 | |
| 201501/01/2015 – 31/12/2015 | 843 t. | 7 t. | 982 t. | 379 t. | - | |
| 201401/01/2014 – 31/12/2014 | 1.4 mio. | 223 t. | 940 t. | 623 t. | - | |
| 201301/01/2013 – 31/12/2013 | 1.4 mio. | 145 t. | 1.1 mio. | 650 t. | - |
Compared to 1.487 companies in Anden teknisk rådgivning
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of ALTRAPHARMA Invest ApS is 34483884.
ALTRAPHARMA Invest ApS is owned by ALTRA 14 ApS and Juniwik Business Management AB.
The management of ALTRAPHARMA Invest ApS consists of Marianne Thrane.
In 2025, ALTRAPHARMA Invest ApS reported a gross profit of DKK -88,915.
ALTRAPHARMA Invest ApS had 1 employee in 2025 according to the Danish CVR register.
ALTRAPHARMA Invest ApS was founded on 18 April 2012.
Claim this page to add your logo and social links. Free to get started.
As of November 26, 2025, ALTRA 14 ApS is registered as an owner of ALTRAPHARMA Invest ApS with an ownership share of 66%.
As of November 26, 2025, is registered as an owner of ALTRAPHARMA Invest ApS with an ownership share of 25%.
ALTRAPHARMA Invest ApS has published its annual report for 2025. Gross profit came to DKK -88,915, and the net result was DKK -84,944.
As of October 21, 2025, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has stepped down as auditor of ALTRAPHARMA Invest ApS.
On October 21, 2025, the company changed its name from ALTRAPHARMA ApS to ALTRAPHARMA Invest ApS.
As of March 25, 2025, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has been appointed auditor of ALTRAPHARMA Invest ApS.
As of March 25, 2025, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of ALTRAPHARMA Invest ApS.
ALTRAPHARMA Invest ApS has published its annual report for 2024. Gross profit came to DKK -42,917, and the net result was DKK 86,556.
ALTRAPHARMA Invest ApS has published its annual report for 2023. Gross profit came to DKK -66,734, and the net result was DKK -67,116.
ALTRAPHARMA Invest ApS has published its annual report for 2022. Gross profit came to DKK -171,936, and the net result was DKK -484,408.
ALTRAPHARMA Invest ApS has published its annual report for 2021. Gross profit came to DKK -76,082, and the net result was DKK -145,775.
ALTRAPHARMA Invest ApS has published its annual report for 2020. Gross profit came to DKK 527,450, and the net result was DKK 407,135.
ALTRAPHARMA Invest ApS has published its annual report for 2019. Gross profit came to DKK 158,006, and the net result was DKK 109,552.
ALTRAPHARMA Invest ApS has published its interim report for the period January 1, 2018 to June 30, 2018.
As of July 3, 2018, Gitte Albert has stepped down as director of ALTRAPHARMA Invest ApS.
ALTRAPHARMA Invest ApS has published its annual report for 2017. Gross profit came to DKK 472,517, and the net result was DKK 269,891.
ALTRAPHARMA Invest ApS has published its annual report for 2016. Gross profit came to DKK 1,154,215, and the net result was DKK 67,430.
As of May 1, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of ALTRAPHARMA Invest ApS.
As of April 30, 2016, AP STATSAUTORISEREDE REVISORER P/S has stepped down as auditor of ALTRAPHARMA Invest ApS.
ALTRAPHARMA Invest ApS has published its annual report for 2015. Gross profit came to DKK 843,480, and the net result was DKK 6,623.
ALTRAPHARMA Invest ApS has published its annual report for 2014. Gross profit came to DKK 1,396,358, and the net result was DKK 223,261.
ALTRAPHARMA Invest ApS has published its annual report for 2013. Gross profit came to DKK 1,373,710, and the net result was DKK 145,072.
ALTRAPHARMA Invest ApS has published its interim report for the period April 18, 2012 to December 31, 2012.
As of January 1, 2013, AP STATSAUTORISEREDE REVISORER P/S has been appointed auditor of ALTRAPHARMA Invest ApS.
As of December 31, 2012, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has stepped down as auditor of ALTRAPHARMA Invest ApS.
As of April 18, 2012, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has been appointed auditor of ALTRAPHARMA Invest ApS.
As of April 18, 2012, Gitte Albert is registered as director of ALTRAPHARMA Invest ApS.
As of April 18, 2012, Marianne Thrane is registered as director of ALTRAPHARMA Invest ApS.
ALTRAPHARMA Invest ApS was founded on April 18, 2012.
Companies in the same industry and area
CVR 15695641
CVR 39298368
CVR 46081226
CVR 42620084
CVR 27068138
